Bone Biologics Ownership 2024 | Who Owns Bone Biologics Now?
Institutional Ownership
0.06%
Insider Ownership
5.21%
Retail Ownership
94.73%
Institutional Holders
1.00
Bone Biologics Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
UBS GROUP AG | 5.10% | - | 33,707 | 33,107 | 5517.83% | 41,123 | Jun 30, 2024 |
HRT FINANCIAL LP | 2.65% | 0.00% | 17,519 | 17,519 | 100.00% | 21,000 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.88% | 0.00% | 5,789 | 1,539 | 36.21% | 7,063 | Jun 30, 2024 |
MFA WEALTH ADVISORS, LLC | 0.06% | 0.00% | 403 | 403 | 100.00% | 492 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 9 | 9 | 100.00% | 11 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -4 | -100.00% | - | Jun 30, 2024 |
ARMISTICE CAPITAL, LLC | - | - | - | -37,000 | -100.00% | - | Jun 30, 2024 |
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
TOWER RESEARCH CAPITAL LLC (TRC) | 0.88% | 0.00% | 5,789 | 1,539 | 36.21% | 7,063 | Jun 30, 2024 |
HRT FINANCIAL LP | 2.65% | 0.00% | 17,519 | 17,519 | 100.00% | 21,000 | Jun 30, 2024 |
MFA WEALTH ADVISORS, LLC | 0.06% | 0.00% | 403 | 403 | 100.00% | 492 | Jun 30, 2024 |
UBS GROUP AG | 5.10% | - | 33,707 | 33,107 | 5517.83% | 41,123 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 9 | 9 | 100.00% | 11 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -4 | -100.00% | - | Jun 30, 2024 |
ARMISTICE CAPITAL, LLC | - | - | - | -37,000 | -100.00% | - | Jun 30, 2024 |
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
UBS GROUP AG | 5.10% | - | 33,707 | 33,107 | 5517.83% | 41,123 | Jun 30, 2024 |
HRT FINANCIAL LP | 2.65% | 0.00% | 17,519 | 17,519 | 100.00% | 21,000 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.88% | 0.00% | 5,789 | 1,539 | 36.21% | 7,063 | Jun 30, 2024 |
MFA WEALTH ADVISORS, LLC | 0.06% | 0.00% | 403 | 403 | 100.00% | 492 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 9 | 9 | 100.00% | 11 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -4 | -100.00% | - | Jun 30, 2024 |
ARMISTICE CAPITAL, LLC | - | - | - | -37,000 | -100.00% | - | Jun 30, 2024 |
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ARMISTICE CAPITAL, LLC | - | - | - | -37,000 | -100.00% | - | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -4 | -100.00% | - | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 9 | 9 | 100.00% | 11 | Jun 30, 2024 |
MFA WEALTH ADVISORS, LLC | 0.06% | 0.00% | 403 | 403 | 100.00% | 492 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.88% | 0.00% | 5,789 | 1,539 | 36.21% | 7,063 | Jun 30, 2024 |
HRT FINANCIAL LP | 2.65% | 0.00% | 17,519 | 17,519 | 100.00% | 21,000 | Jun 30, 2024 |
UBS GROUP AG | 5.10% | - | 33,707 | 33,107 | 5517.83% | 41,123 | Jun 30, 2024 |
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
HRT FINANCIAL LP | 2.65% | 0.00% | 17,519 | 17,519 | 100.00% | 21,000 | Jun 30, 2024 |
MFA WEALTH ADVISORS, LLC | 0.06% | 0.00% | 403 | 403 | 100.00% | 492 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 9 | 9 | 100.00% | 11 | Jun 30, 2024 |
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ARMISTICE CAPITAL, LLC | - | - | - | -37,000 | -100.00% | - | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -4 | -100.00% | - | Jun 30, 2024 |
Bone Biologics Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
VANGUARD INDEX FUNDS | 0.00% | 33,461 | - | - | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 15,816 | - | - | Feb 29, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 5,900 | - | - | Feb 29, 2024 |
Bone Biologics Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Jun, 24 | 1 | -75.00% |
31 Mar, 24 | 4 | 100.00% |
31 Dec, 23 | 2 | -75.00% |
30 Sep, 23 | 8 | 14.29% |
30 Jun, 23 | 7 | -12.50% |
31 Mar, 23 | 8 | -33.33% |
31 Dec, 22 | 12 | 500.00% |
30 Sep, 22 | 2 | -33.33% |
30 Jun, 22 | 3 | - |
31 Mar, 22 | 3 | - |
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Jun, 24 | 403 | -99.04% |
31 Mar, 24 | 41,854 | 3305.53% |
31 Dec, 23 | 1,229 | -99.63% |
30 Sep, 23 | 330,640 | -18.32% |
30 Jun, 23 | 404,792 | -83.83% |
31 Mar, 23 | 2,502,773 | 10.56% |
31 Dec, 22 | 2,263,720 | 5376.12% |
30 Sep, 22 | 41,338 | -12.60% |
30 Jun, 22 | 47,299 | -17.98% |
31 Mar, 22 | 57,666 | - |
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Jun, 24 | 0.06% | 0.15% |
31 Mar, 24 | 6.33% | 11968.43% |
31 Dec, 23 | 0.23% | 0.21% |
30 Sep, 23 | 10.55% | 6.32% |
30 Jun, 23 | 12.91% | 141.37% |
31 Mar, 23 | 3.02% | 40.44% |
31 Dec, 22 | 2.73% | 109741.88% |
30 Sep, 22 | 0.05% | 1530.65% |
30 Jun, 22 | 0.06% | 1178.45% |
31 Mar, 22 | 0.07% | - |
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Jun, 24 | 1 | -66.67% |
31 Mar, 24 | 3 | - |
31 Dec, 23 | - | -100.00% |
30 Sep, 23 | 6 | 200.00% |
30 Jun, 23 | 2 | -50.00% |
31 Mar, 23 | 4 | -66.67% |
31 Dec, 22 | 12 | 1100.00% |
30 Sep, 22 | 1 | -50.00% |
30 Jun, 22 | 2 | -33.33% |
31 Mar, 22 | 3 | - |
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Jun, 24 | - | - |
31 Mar, 24 | - | -100.00% |
31 Dec, 23 | 2 | - |
30 Sep, 23 | 2 | -60.00% |
30 Jun, 23 | 5 | 150.00% |
31 Mar, 23 | 2 | - |
31 Dec, 22 | - | - |
30 Sep, 22 | - | - |
30 Jun, 22 | - | - |
31 Mar, 22 | - | - |
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun, 24 | 1 | -75.00% | 403 | -99.04% | 0.06% | 0.15% | 1 | -66.67% | - | - |
31 Mar, 24 | 4 | 100.00% | 41,854 | 3305.53% | 6.33% | 11968.43% | 3 | - | - | -100.00% |
31 Dec, 23 | 2 | -75.00% | 1,229 | -99.63% | 0.23% | 0.21% | - | -100.00% | 2 | - |
30 Sep, 23 | 8 | 14.29% | 330,640 | -18.32% | 10.55% | 6.32% | 6 | 200.00% | 2 | -60.00% |
30 Jun, 23 | 7 | -12.50% | 404,792 | -83.83% | 12.91% | 141.37% | 2 | -50.00% | 5 | 150.00% |
31 Mar, 23 | 8 | -33.33% | 2,502,773 | 10.56% | 3.02% | 40.44% | 4 | -66.67% | 2 | - |
31 Dec, 22 | 12 | 500.00% | 2,263,720 | 5376.12% | 2.73% | 109741.88% | 12 | 1100.00% | - | - |
30 Sep, 22 | 2 | -33.33% | 41,338 | -12.60% | 0.05% | 1530.65% | 1 | -50.00% | - | - |
30 Jun, 22 | 3 | - | 47,299 | -17.98% | 0.06% | 1178.45% | 2 | -33.33% | - | - |
31 Mar, 22 | 3 | - | 57,666 | - | 0.07% | - | 3 | - | - | - |
Bone Biologics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
Bone Biologics Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2024 | 6 | 2 | 300.00% |
Q3 2023 | 16 | - | - |
Q1 2023 | 14 | 4 | 350.00% |
Q3 2022 | 6 | - | - |
Q1 2022 | 5 | - | - |
Q4 2021 | 6 | 4 | 150.00% |
Q1 2020 | 2 | - | - |
Q3 2019 | 4 | - | - |
Q2 2019 | 4 | - | - |
Q1 2019 | 3 | - | - |
Q4 2018 | 2 | - | - |
Q3 2018 | - | - | - |
Q1 2018 | 5 | - | - |
Q4 2017 | 1 | - | - |
Q3 2017 | 2 | 2 | 100.00% |
Q1 2017 | 2 | - | - |
Q3 2016 | 2 | 1 | 200.00% |
Q2 2016 | 2 | 1 | 200.00% |
Q1 2016 | 5 | - | - |
Q4 2015 | 22 | 9 | 244.44% |
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2024 | - | - | - |
Q3 2023 | 10 | - | - |
Q1 2023 | - | - | - |
Q3 2022 | - | - | - |
Q1 2022 | - | - | - |
Q4 2021 | - | - | - |
Q1 2020 | 2 | - | - |
Q3 2019 | 4 | - | - |
Q2 2019 | 4 | - | - |
Q1 2019 | 2 | - | - |
Q4 2018 | 2 | - | - |
Q3 2018 | - | - | - |
Q1 2018 | - | - | - |
Q4 2017 | - | - | - |
Q3 2017 | - | - | - |
Q1 2017 | - | - | - |
Q3 2016 | - | - | - |
Q2 2016 | - | - | - |
Q1 2016 | 1 | - | - |
Q4 2015 | - | 7 | - |
Bone Biologics Peer Ownership
Ticker | Company |
---|---|
RPID | Rapid Micro Biosystems, Inc. |
INVO | INVO Bioscience, Inc. |
TIVC | Tivic Health Systems, Inc. |
NUWE | Nuwellis, Inc. |
RSLS | ReShape Lifesciences Inc. |
BJDX | Bluejay Diagnostics, Inc. |
HSCS | Heart Test Laboratories, Inc. |
MOTS | Motus GI Holdings, Inc. |
TNON | Tenon Medical, Inc. |
SINT | Sintx Technologies, Inc. |
NAOV | NanoVibronix, Inc. |
VVOS | Vivos Therapeutics, Inc. |
BBLG Ownership FAQ
Who Owns Bone Biologics?
Bone Biologics is owned by institutional shareholders (0.06%), insiders (5.21%), and public (94.73%). The largest institutional shareholder of Bone Biologics is UBS GROUP AG (5.10% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).
Who are the major institutional shareholders of Bone Biologics?
Bone Biologics's major institutional shareholders are UBS GROUP AG, HRT FINANCIAL LP, TOWER RESEARCH CAPITAL LLC (TRC), MFA WEALTH ADVISORS, LLC, and BANK OF AMERICA CORP /DE/. The top five shareholders own together 8.69% of the company's share outstanding.
How many Bone Biologics shareholders are there?
As of Jun 2024, there are 1 institutional shareholders of Bone Biologics.
What percentage of Bone Biologics is owned by UBS GROUP AG?
UBS GROUP AG owns 33.71K shares of Bone Biologics, representing 5.10% of the company's total shares outstanding, valued at $41.12K (as of Jun 2024).
What percentage of Bone Biologics is owned by HRT FINANCIAL LP?
As of Jun 2024, HRT FINANCIAL LP holds 17.52K shares of Bone Biologics (BBLG), compromising 2.65% of the company, valued at $21K.
What percentage of Bone Biologics is owned by TOWER RESEARCH CAPITAL LLC (TRC)?
TOWER RESEARCH CAPITAL LLC (TRC) is the third largest holder of Bone Biologics. The company owns 5.79K of the company's shares outstanding (worth $7.06K).